Navigation Links
UT Dallas study suggests new approach to fight lung cancer
Date:6/18/2013

/p>

"Cancer cells not only make significantly more heme, we also found they uptake more heme from the blood," said Zhang, who holds the Cecil H. and Ida Green Distinguished Chair in Systems Biology Science.

Zhang and Hooda then treated the matched set of lung cancer and normal lung cells with a heme inhibitor called succinyl acetone. The chemical blocks cells from synthesizing heme.

Other researchers have previously studied the ability of succinyl acetone to inhibit growth of various types of cancer cells, but until the UT Dallas study, Zhang said it was not known whether those effects were unique to cancer in general or how the compound might affect normal cells.

"Before our study, scientists didn't know whether there was any difference in effect between cancer cells and normal cells," Zhang said. "Now we know that this compound doesn't have much effect on normal cells, but it does have an effect on lung cancer cells."

Inhibiting the cancer cells' ability to produce heme affected those cells dramatically, said Hooda, who was the lead author of the study.

"Suppressing heme availability reduced the lung cancer cells' ability to use oxygen, and hence the cells' ability to proliferate and migrate," he said. "The cultured cancer cells we studied stopped proliferating and eventually died."

Zhang said a key finding was that normal cells don't need that much heme to function properly.

"When you inhibit heme synthesis or deplete heme, it doesn't affect normal cells too much," she said. "It selectively affects cancer cells. That's the beauty of our work.

"Because inhibiting heme effectively arrested the progression of lung cancer cells, our findings could positively impact research on lung cancer biology and therapeutics."

The National Cancer Institute estimates that 228,000 new cases of lung cancer will be diagnosed and more than 159,000 deaths from the disease will occur in the U.S. in
'/>"/>

Contact: Amanda Siegfried
amanda.siegfried@utdallas.edu
972-883-4335
University of Texas at Dallas
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Texas Back Institute Becomes Official Spine Specialist for FC Dallas and the Frisco RoughRiders
2. Dallas-Fort Worth Brace for West Nile Spraying
3. Dallas, Fort Worth Brace for West Nile Spraying
4. UT Dallas engineers identify material that reduces pollution from diesel engines
5. Dallas Launches Insecticide Spraying Against West Nile Virus
6. UT Southwestern named the official health care team of the Dallas Stars
7. Group Insurance Brokers Give Back to Dallas Non-Profits and Military Fund
8. Artisan Business Group to Host EB-5 Investment Workshop in Dallas January 16, 2013
9. Eco Smart Energy, LLC Successfully Installs Eco-Friendly, Cost Saving Sun Equinox System at Dallas Stars’ Dr. Pepper StarCenter
10. Del Taco Connects With Itxtdeals.com to Expand Text Message Marketing to Dallas-Fort Worth
11. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... (PRWEB) July 22, 2014 According to ... Health care, Automobile, Aerospace & Defense, Marine and Mining) ... Middle East, and Rest of the world) - Forecast ... is expected to grow at a CAGR 8.00% to ... Europe is estimated to grow at a CAGR of ...
(Date:7/22/2014)... Dimension One Spas’ retailers across the ... all models during the “Let’s Take This Outside” Summer ... http://www.d1spas.com/financing for more information and to apply. ... offers a wide variety of outdoor hot tubs with ... music, customizable massage, and personal controls. , ...
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- People who suffer ... for a rise in blood pressure, a new study ... health problems and even early death, but few studies ... may be one of the causes, according to the ... people who had been separated or divorced for about ...
(Date:7/22/2014)... has received a five-year, $3 million grant to ... neglect and maltreatment during childhood leave molecular marks ... life. , The Center for Biomarker Research and ... in collaboration with Duke University School of Medicine, ... by the National Institutes of Health, National Institute ...
(Date:7/22/2014)... July 22, 2014 BlogHer, Inc. ... women, this year celebrates its tenth anniversary where it ... of attendees, including community leaders from the new women’s ... every consumer vertical, will converge in San Jose this ... and a “selfiebration” of social technology. , BlogHer’s ...
Breaking Medicine News(10 mins):Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Global Actuators Market Estimated to Reach $59.32 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2Health News:VCU receives grant to study molecular marks left by childhood adverse experiences 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4
... Calif., Aug. 6 IRIDEX Corporation (NASDAQ: IRIX ) today ... the market closes on Thursday, August 13, 2009. ... call with the investment community at 5:00 p.m. Eastern Time ... discuss the results of the quarter and other business developments. , ...
... ,Is the White House looking to intimidate and silence opponents?, asks FRC,s ... In a web video released today, Family Research Council ( FRC ... send the White House any email or health care messages deemed "fishy." ... ) , , Family Research Council President ...
... OAK BROOK, Ill., Aug. 6 SedationFacts.org, ... gastroenterology fellows, announces enhancements to the sedation administration standards ... administration information and reliable links to other state resources. ... regulations governing sedation administration by nursing personnel vary from ...
... on the way for anyone who has ever gotten lost ... is in the form of health-care signage symbols being developed ... other U.S. universities. These symbols will be tested this ... of surveys taken among the populations in three Midwestern cities, ...
... viral, bacterial infections, study finds , THURSDAY, Aug. ... appears able to identify people who,ve been exposed to ... flu, even before symptoms develop. , In a study ... a live cold virus, respiratory syncytial virus or influenza ...
... EXTON, Pa., Aug. 6 ViroPharma Incorporated (Nasdaq: VPHM ... clinical trial for NTCD (non-toxigenic Clostridium difficile ), a novel ... NTCD contains the spores of a non-toxin producing strain of ... "Colonization of the large bowel with non-toxin producing strains of ...
Cached Medicine News:Health News:White House Launches 'Fishy' Expedition 2Health News:Sedationfacts.org Enhances State-Specific Site Content, Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and Use 2Health News:Sedationfacts.org Enhances State-Specific Site Content, Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and Use 3Health News:Sedationfacts.org Enhances State-Specific Site Content, Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and Use 4Health News:UC design research points the way so you won't get lost at the hospital 2Health News:UC design research points the way so you won't get lost at the hospital 3Health News:UC design research points the way so you won't get lost at the hospital 4Health News:Cold, Flu or Pneumonia? Answer May Lie in Blood Test 2Health News:ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program 2Health News:ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program 3Health News:ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program 4
(Date:7/22/2014)... July 22, 2014  Decision Resources Group finds that the ... will remain relatively stagnant at a value of ... that percutaneous coronary intervention (PCI) volumes are growing faster in ... such as the United States and ... driven by the increase in penetration of PCI procedures relative ...
(Date:7/22/2014)... WASHINGTON , July 22, 2014 ... "Ensuring Seniors Access to Local Pharmacies Act of ... Medicare Part D would undermine the availability of ... spending by $21 billion over the next 10 ... Company released by the Pharmaceutical Care Management Association ...
(Date:7/22/2014)... July 22, 2014  Decision Resources Group finds ... (MS) patients currently treated with Biogen Idec,s ... experienced flushing and/or gastrointestinal events while on ... currently experiencing these side effects, signifying either ... management of such events. In the end, ...
Breaking Medicine Technology:The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3
... Pa., Dec. 29, 2010 Endo Pharmaceuticals (Nasdaq: ... and Drug Administration (FDA) has approved FORTESTA Gel for ... known as hypogonadism. Symptoms associated with Low T include ... of energy, mood depression, regression of secondary sexual characteristics ...
... Dr. David Samadi, the Vice Chairman, Department of Urology, ... The Mount Sinai Medical Center in New York City, ... completion of six successful robotic prostate cancer treatment ... three of which were televised live, Samadi demonstrated his ...
Cached Medicine Technology:Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 2Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 3Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 4Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 5Endo Pharmaceuticals Receives FDA Approval for FORTESTA™ (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone 6Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success 2Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success 3
... is designed for arthroscopic or open suturing ... It features heavy-gauge suture hooks and the ... hooks allow precise suture placement in otherwise ... System is for use with #2/0 to ...
Suture Cutter, 15 Up Curve...
Portal accessory instrument set. Set also includes a package of 8 mm Guide Wires (.15 cm x 38 cm), and Sterilization Tray....
...
Medicine Products: